Followers | 195 |
Posts | 11152 |
Boards Moderated | 2 |
Alias Born | 06/20/2022 |
![](https://investorshub.advfn.com/uicon/824868.png?cb=1724929129)
Tuesday, January 31, 2023 9:38:41 AM
![Bullish](/static/images/ih2-bull.png)
Recent CNTX News
- Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:17:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:07:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:18:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:15:17 PM
- Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/24/2024 09:07:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/24/2024 08:55:48 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/12/2024 08:04:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:33:59 AM
- Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:50:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:34:52 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:21 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/31/2024 08:06:51 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/24/2024 08:15:19 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/24/2024 11:31:07 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/10/2024 08:00:06 PM
- Context Therapeutics Reports First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 05/08/2024 08:06:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:03:39 PM
- Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 • GlobeNewswire Inc. • 05/02/2024 11:31:53 AM
- Context Therapeutics Announces $100 Million Private Placement • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers • GlobeNewswire Inc. • 04/01/2024 11:30:00 AM
- Context Therapeutics Reports Full Year 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/21/2024 11:43:24 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM